cant help but think this is helpful. It means the FDA is on side with the patient population and will have a bias toward approval. The negative for PER is clearly that they are not a Major US drug producer (as the FDA is biased toward approving drugs from its own).......but of the 2 I hope the former is a stronger pull factor......you need to have the patient groups onside which I believe PER does
cant help but think this is helpful. It means the FDA is on side...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
